Advanced Gastrointestinal Stromal Tumors (GIST)
Oncology
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Advanced Gastrointestinal Stromal Tumors (GIST)?
There are 1 clinical trial targeting Advanced Gastrointestinal Stromal Tumors (GIST) tracked by BioSniper.
What is the prevalence of Advanced Gastrointestinal Stromal Tumors (GIST)?
The estimated prevalence of Advanced Gastrointestinal Stromal Tumors (GIST) is approximately 30.0 per 100,000 population.
Deep-dive into Advanced Gastrointestinal Stromal Tumors (GIST)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis